SCHEMBL5724341

SCHEMBL5724341

CCONC(=O)c1csc(N2CC(O[Si](c3ccccc3)(c3ccccc3)C(C)(C)C)C2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCD O00767 1/20 0.35
HDAC1 Q13547 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC3 O15379 1/20 0.33
HDAC2 Q92769 1/20 0.33
PIM1 P11309 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 2/20 0.33
MAPT P10636 2/20 0.33
RAB9A P51151 2/20 0.33
NPC1 O15118 2/20 0.33
ACACB O00763 1/20 0.33
ACKR3 P25106 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PIN1 Q13526 1/20 0.33
OPRK1 P41145 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5724026 0.89 PARP1 (0.37) SCDSMN1; SMN2ACKR3L3MBTL1PIN1
SCHEMBL5723906 0.88 OGA (0.38) SCDHDAC1HDAC8HDAC6HDAC3
SCHEMBL5723862 0.86 RAB9A (0.43) SMN1; SMN2ALDH1A1LMNAMAPTRAB9A
SCHEMBL5723546 0.86 OGA (0.42) SCDACACBL3MBTL1PIN1HRH3
SCHEMBL5724316 0.86 TDP1 (0.43) HDAC3HDAC2SMN1; SMN2ALDH1A1LMNA
SCHEMBL5724070 0.85 SCD (0.48) SCDSMN1; SMN2RAB9ANPC1L3MBTL1
SCHEMBL5724728 0.85 PTGER1 (0.41) SCDALDH1A1L3MBTL1
SCHEMBL5724219 0.85 TNKS (0.43) SCDACKR3KMT2A
SCHEMBL5724301 0.84 HIF1A (0.37) SCDSMN1; SMN2ALDH1A1ACKR3L3MBTL1
SCHEMBL5726171 0.83 OGA (0.43) RAB9ANPC1ACKR3PIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1340757-B1 1-METHYLCARBAPENEM DERIVATIVES SANKYO CO (JP) 2006-10-11 EP disclosed
US-7001897-B2 1-methylcarbapenem derivatives SANKYO COMPANY, LIMITED (JP) 2006-02-21 US disclosed
US-20040014962-A1 1-Methylcarbapenem derivatives SANKYO COMPANY, LIMITED (JP) 2004-01-22 US disclosed
EP-1340757-A1 1-METHYLCARBAPENEM DERIVATIVES Sankyo Company, Limited (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014962-A1 1-Methylcarbapenem derivatives CD14, CPT1A, ACMSD SCD 54/4885HDAC1 370/4885HDAC8 2587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.